This Lexvo.org page describes the entity referred to by the URI http://lexvo.org/id/wordnet/30/noun/phase_III_clinical_trial_1_04_00. A machine-readable RDF version of this description is provided here.
| rdfs:comment | a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA ('en' language string) |
| rdfs:label | phase III clinical trial ('en' language string) |
| rdfs:label | phase III ('en' language string) |
| lvont:broader | lexvo:wordnet/30/noun/clinical_trial_1_04_00 |
| lvont:label | lexvo:term/eng/phase%20III%20clinical%20trial |
| lvont:label | lexvo:term/eng/phase%20III |
| lvont:nearlySameAs | http://purl.org/vocabularies/princeton/wn30/synset-phase_III_clinical_trial-noun-1 |
| skos:note | This resource corresponds to the meaning of the gloss text. It shares its meaning with that of the synonym set rather than denoting the WordNet synset. ('en' language string) |
Lexvo.org 2008-2024 Gerard de Melo. Contact Data Sources Legal Information / Imprint